CN104069253A - Traditional Chinese medicine for treating tumors - Google Patents
Traditional Chinese medicine for treating tumors Download PDFInfo
- Publication number
- CN104069253A CN104069253A CN201410272959.0A CN201410272959A CN104069253A CN 104069253 A CN104069253 A CN 104069253A CN 201410272959 A CN201410272959 A CN 201410272959A CN 104069253 A CN104069253 A CN 104069253A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine
- tumor
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 29
- 241000222336 Ganoderma Species 0.000 claims abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 241000208340 Araliaceae Species 0.000 claims description 13
- 230000000694 effects Effects 0.000 abstract description 9
- 201000011510 cancer Diseases 0.000 abstract description 7
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 13
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 208000015634 Rectal Neoplasms Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000003716 mesoderm Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010038038 rectal cancer Diseases 0.000 description 3
- 201000001275 rectum cancer Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 241001600609 Equus ferus Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000000349 mediastinal cancer Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000018280 neoplasm of mediastinum Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating tumors. The medicine is prepared from the following material medicines in parts by weight: 6-9 parts of ginseng, 5-8 parts of turtle shells, 5-10 parts of prepared rehmannia roots, 5-6 parts of lucid ganoderma and 3-6 parts of fruit of Chinese wolfberry. By combining treatment effects of each medicine component, the traditional Chinese medicine disclosed by the invention can reduce tumors in stages until disappearing for malignant solid tumors of each part and each tissue, and has an effective rate of over 90%.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly relate to a kind of Chinese medicine for the treatment of tumor.
Background technology
Tumor is genopathy in itself.All-environment and hereditary carcinogenic factor is to work in coordination with or sequential mode causes DNA infringement, thereby activate proto-oncogene and (or) deactivation tumor suppressor gene, add the change of apoptosis regulator gene and (or) DNA-repair gene, then cause the abnormal of expression, target cell is transformed.The cell being converted is first the hypertrophy of clone's property more, through a very long multistage evolution process, one of them clones relatively unconfined amplification, pass through addition mutation, optionally form the sub-clone (heterogeneousization) with different characteristics, thereby obtain the ability (vicious transformation) that infiltrates and shift, form malignant tumor.
Cancer, as a class malignant tumor, is developed by normal cell in human body.Normal cell becomes after cancerous cell, and just as a runaway wild horse, human body cannot retrain it, produces so-called " supernormal growth ".Supernormal growth is for the normal hypertrophy of cell.Human body cell has a growth, breeding, aging, dead process.After aging cell death, just have newborn cell and replace it, to maintain the normal function of body tissue and organ.Visible, human body overwhelming majority cell can hypertrophy.But this Normocellular hypertrophy is limited, the hypertrophy of cancerous cell is endless.Just because of this neoplasm, human body a large number of nutrients is consumed.Meanwhile, cancerous cell can also discharge multiple toxin, makes human body produce series of symptoms.
If find and treatment not in time, cancerous cell can also be transferred to whole body growth and breeding everywhere, finally cause that human body is become thin, unable, anemia, inappetence, heating and organ function impaired etc., its consequence is very serious.
Chinese traditional treatment cancer take the whole dialectical theory of the traditional Chinese medical science as basis, theoretical in conjunction with acupuncture, the induction of cancer health is theoretical, immunity anticancer is theoretical, physical medicine is theoretical produces, it be a kind of anticancer, saving one's life combines and Therapeutic Method with effecting a permanent cure.Anticancer to improve mesenchyma stroma of tumors cell function, (that is: make originally mesenchyma stroma of tumors cell rise and support and the mesenchyma stroma of tumors of Nutrition is transformed into the Interstitial cell that tumor epithelial cell cell is played to Inhibiting and protective function, cancerous cell loses living environment and is destroyed); With QI and blood regulating, regulating YIN and YANG balance, maintain normal vital signs and save one's life; With training revisal gas, produce antibody, cleaning " malicious source " and effecting a permanent cure.At present not yet there is the particularly preferred Chinese medicine of therapeutic effect to occur reducing the misery of tumor patient.
Summary of the invention
The technical problem to be solved in the present invention is in order to overcome in prior art, the deficiency that treatment tumor cycle length, weak curative effect etc. exist, thus the technical scheme providing is:
A Chinese medicine for the treatment of tumor, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: Radix Ginseng 6-9 part, Carapax Trionycis 5-8 part, Radix Rehmanniae Preparata 5-10 part, Ganoderma 5-6 part, Fructus Lycii 3-6 part.
Described a kind of Chinese medicine for the treatment of tumor, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 6 parts of people Ginseng, 5 parts of Carapax Trionycis, 5 parts, Radix Rehmanniae Preparata, 5 parts of Ganodermas, 3 parts of Fructus Lycii.
Described a kind of Chinese medicine for the treatment of tumor, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 9 parts of people Ginseng, 8 parts of Carapax Trionycis, 10 parts, Radix Rehmanniae Preparata, 6 parts of Ganodermas, 6 parts of Fructus Lycii.
Described a kind of Chinese medicine for the treatment of tumor, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 8 parts of people Ginseng, 7 parts of Carapax Trionycis, 8 parts, Radix Rehmanniae Preparata, 5.5 parts of Ganodermas, 5 parts of Fructus Lycii.
Adopt the beneficial effect of technique scheme to be:
In prescription of the present invention, Radix Ginseng has strongly invigorating primordial QI, the effect of invigorating the spleen to benefit the lung, promoting the production of body fluid to quench thirst, the increasing intelligence of calming the nerves.Carapax Trionycis has nourishing YIN for suppressing the hyperactive YANG, brings down a fever except steaming, and the effect of hard masses softening and resolving.Radix Rehmanniae Preparata has enriches blood, YIN nourishing, and spermatogenesis is mended marrow, the effect of health-care.Ganoderma cures mainly asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.Animal pharmacology shows experiment: Ganoderma has inhibitory action to nervous system, and blood circulation has blood pressure lowering and strengthens the effect of cardiac contractile force, and respiratory system is had to phlegm-dispelling functions, in addition, also has hepatoprotective, improves immunologic function, antibacterially waits effect.Fructus Lycii has the effect of replenishing YIN and blood, nourishing the liver and kidney, anticancer, replenishing vital essence to improve eyesight.In conjunction with the therapeutic efficiency of above-mentioned various ingredients, the present invention is directed to each position of human body, tissue, each character malignant entity tumor has can make tumor occur stage by stage dwindling until disappear.
The specific embodiment
Treat a Chinese medicine for tumor, this medicine is formed by the crude drug compatibility of following parts by weight: Radix Ginseng 6-9 part, Carapax Trionycis 5-8 part, Radix Rehmanniae Preparata 5-10 part, Ganoderma 5-6 part, Fructus Lycii 3-6 part.
Optimum ratio is: 6 parts of people Ginseng, 5 parts of Carapax Trionycis, 5 parts, Radix Rehmanniae Preparata, 5 parts of Ganodermas, 3 parts of Fructus Lycii.
Optimum ratio is: 9 parts of people Ginseng, 8 parts of Carapax Trionycis, 10 parts, Radix Rehmanniae Preparata, 6 parts of Ganodermas, 6 parts of Fructus Lycii.
Optimum ratio is: 8 parts of people Ginseng, 7 parts of Carapax Trionycis, 8 parts, Radix Rehmanniae Preparata, 5.5 parts of Ganodermas, 5 parts of Fructus Lycii.
Preparation method: get said medicine co-grinding, cross 120 mesh sieves and get final product;
Instructions of taking: every day three times, each 9g, with under warm water clothes.
This Chinese prescription is verified through clinical case, man's 52 examples, and Ms's 36 examples, cure 80 examples, and total effective rate reaches more than 90%, is below clinical treatment model case:
Case 1, Zhao Hongchen, man, 64 years old, 7 * 9cm mediastinal tumor, symptom is compressing esophagus, feed difficulty, after treatment a year and a half, tumor is dissolved and is disappeared, transference cure (CT contrast);
Case 2, Li Yingxuan, man, 53 years old, 8 * 9cm mesothelioma was accompanied right breast the 3rd rib pathologisch Bruch, and symptom is suppressed for breathing heavily, and violent chest pain is treated lump after 2 years and is dissolved disappearance, pathologisch Bruch healing, transference cure (CT contrast);
Case 3, Ruan Xing, man, 62 years old, esophageal carcinoma postoperative metastasis, 5 * 6cm hepatocarcinoma, symptom for becoming thin, unable, treat after 2 years lump and dissolve and disappear, transference cure (CT contrast);
Case 4, Wu's clear statement, man, 59 years old, 4 * 3cm pulmonary carcinoma, symptom for breathing heavily, heating, hemoptysis, treat after six months lump and dissolve and disappear, transference cure (CT contrast);
Case 5, Li great Lian, man, 41 years old, 3 * 4cm cancer of pancreas, symptom is obstructive jaundice, pain, treats lump after three months and dissolves disappearance, transference cure (CT contrast) cruelly;
Case 6, Dong Wengui, female, 58 years old, postoperative rectal cancer shifted, hepatocarcinoma, symptom for becoming thin, unable, treat focus calcification after 3 years, transference cure (CT contrast);
Case 7, Tan Shanrong, man, 74 years old, gastric cancer was invaded profit pancreas hilus pulumonis and is shifted, symptom for becoming thin, unable, have a stomach-ache, dry cough, after treating 2 months, symptom disappears substantially, focus is reduced into 5.0 * 5.1cm (CT contrast) by 5.2 original * 5.6cm;
Case 8, Lin Zhihui, man, 73 years old, bladder cancer 3.0cm * 2.6cm * 3.0cm, symptom for becoming thin, unable, hematuria, pain, treat after 3 years lump and dissolve and disappear, transference cure (B ultrasonic contrast);
Case 9, Liu Qinghai, man, 55 years old, rectal cancer, companion's diffuse liver cancer shifts, maximum 5.1cm * 3.9cm, symptom for becoming thin, unable, acute pain, treat lump after 12 days and is reduced into 4.3cm * 3.3cm, present symptom is stablized (B ultrasonic contrast);
Case 10, Li Xiurong, female, 74 years old, rectal cancer shifted, symptom for having blood in stool, become thin, unable, treat focus tumor large-area displays after 23 days and lose activity, transference cure, stable disease (contrast of intestinal mirror).
Claims (4)
1. a Chinese medicine for the treatment of tumor, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: Radix Ginseng 6-9 part, Carapax Trionycis 5-8 part, Radix Rehmanniae Preparata 5-10 part, Ganoderma 5-6 part, Fructus Lycii 3-6 part.
2. a kind of Chinese medicine for the treatment of tumor according to claim 1, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 6 parts of people Ginseng, 5 parts of Carapax Trionycis, 5 parts, Radix Rehmanniae Preparata, 5 parts of Ganodermas, 3 parts of Fructus Lycii.
3. a kind of Chinese medicine for the treatment of tumor according to claim 1, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 9 parts of people Ginseng, 8 parts of Carapax Trionycis, 10 parts, Radix Rehmanniae Preparata, 6 parts of Ganodermas, 6 parts of Fructus Lycii.
4. a kind of Chinese medicine for the treatment of tumor according to claim 1, is characterized in that: this medicine is formed by the crude drug compatibility of following parts by weight: 8 parts of people Ginseng, 7 parts of Carapax Trionycis, 8 parts, Radix Rehmanniae Preparata, 5.5 parts of Ganodermas, 5 parts of Fructus Lycii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410272959.0A CN104069253A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine for treating tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410272959.0A CN104069253A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine for treating tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104069253A true CN104069253A (en) | 2014-10-01 |
Family
ID=51591119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410272959.0A Pending CN104069253A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine for treating tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104069253A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382172A (en) * | 2014-12-02 | 2015-03-04 | 东莞市荷花食品有限公司 | Pleurotus eryngii health beverage with anti-tumor effect and preparation method thereof |
| CN105727183A (en) * | 2016-03-18 | 2016-07-06 | 杨菁 | Antitumor traditional Chinese medicine for internal medicine department |
| CN108619422A (en) * | 2018-05-23 | 2018-10-09 | 杜美丽 | A kind of antitumor Chinese and diplocardia biological heat energy therapy |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1836702A (en) * | 2005-03-21 | 2006-09-27 | 兰州殿稳医疗制品有限公司 | Medicine for treating tumour and its preparing method |
| CN102114099A (en) * | 2011-02-17 | 2011-07-06 | 邓鑫 | Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof |
| CN103845524A (en) * | 2014-03-13 | 2014-06-11 | 成都中医药大学 | Traditional Chinese medicine composition for treating insufficient kidney essence syndrome after tumor radiotherapy and chemotherapy as well as preparation method and application thereof |
-
2014
- 2014-06-18 CN CN201410272959.0A patent/CN104069253A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1836702A (en) * | 2005-03-21 | 2006-09-27 | 兰州殿稳医疗制品有限公司 | Medicine for treating tumour and its preparing method |
| CN102114099A (en) * | 2011-02-17 | 2011-07-06 | 邓鑫 | Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof |
| CN103845524A (en) * | 2014-03-13 | 2014-06-11 | 成都中医药大学 | Traditional Chinese medicine composition for treating insufficient kidney essence syndrome after tumor radiotherapy and chemotherapy as well as preparation method and application thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104382172A (en) * | 2014-12-02 | 2015-03-04 | 东莞市荷花食品有限公司 | Pleurotus eryngii health beverage with anti-tumor effect and preparation method thereof |
| CN105727183A (en) * | 2016-03-18 | 2016-07-06 | 杨菁 | Antitumor traditional Chinese medicine for internal medicine department |
| CN108619422A (en) * | 2018-05-23 | 2018-10-09 | 杜美丽 | A kind of antitumor Chinese and diplocardia biological heat energy therapy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104069253A (en) | Traditional Chinese medicine for treating tumors | |
| CN104258101A (en) | Medicated diet bag having anti-chemotherapy function and preparation method thereof | |
| CN103550435B (en) | Traditional Chinese medicine for treating tristimania | |
| CN107837380A (en) | A kind of Chinese medicine composition for treating cancer pain and preparation method thereof | |
| CN103520482A (en) | Healthful medicinal liquor for tonifying kidney and invigorating yang and preparation method thereof | |
| CN110201128B (en) | Traditional Chinese medicine preparation for treating acne with syndrome of intermingled phlegm and blood stasis and preparation method thereof | |
| CN102614364A (en) | Traditional Chinese medicine combination for treating swelling and pain in throat | |
| CN104258127A (en) | Traditional Chinese medicinal preparation for treating cutaneous hemangioma | |
| CN103598503B (en) | One is treated and is prevented psoriatic buckwheat raw sophora flower porridge | |
| CN105535430A (en) | Traditional Chinese medicine for treating yin deficiency with pathogen lingering syndrome type palatalcarbunculosis | |
| CN103816458B (en) | A kind of Chinese medicine for the treatment of deficiency of spleen-QI pattern of syndrome preceeded menorrhea | |
| CN104971317A (en) | Traditional Chinese medicine for treating tumors | |
| CN104585793A (en) | Tilapia ball food | |
| CN105212142A (en) | A kind of aizoon stonecrop antitoxic heart-soothing and sedative soup stock and production method thereof | |
| CN104137939A (en) | Aeschynomene indica tea capable of dispelling wind and improving eyesight and production method thereof | |
| CN104544013A (en) | Formula and production method of black sesame seed soup capable of benefiting intelligence and invigorating brain | |
| CN105212213A (en) | A kind of Momordica grosvenori invigorating brain and relieving mental uneasiness electuary and production method | |
| CN104939049A (en) | Eriobotrya japonica dissolved granules capable of nourishing and invigorating brain and production method thereof | |
| CN103386056B (en) | Anti-tumor traditional Chinese medicine troche and preparation method thereof | |
| CN104026677A (en) | Lysionotus pauciflorus soup capable of dissipating blood stasis and alleviating pain and production method thereof | |
| CN109700954A (en) | It is a kind of to treat cirrhosis, Chinese medicine of liver cancer and preparation method thereof | |
| CN105125825A (en) | Traditional Chinese medicinal composition for treating influenza | |
| CN107184813A (en) | It is a kind of for medicine of anti-curing oncoma and preparation method thereof and application | |
| CN105816715A (en) | Traditional Chinese medicine composition for treating reactive depression caused by liver depression and spleen deficiency | |
| CN106492132A (en) | A kind of Chinese medicine composition for treating dysmenorrhoea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: HAN JIULONG Effective date: 20150407 Owner name: WU QINGHE Free format text: FORMER OWNER: SHIJIAZHUANG MENGYU BIOLOGICAL SCIENCE + TECHNOLOGY CO., LTD. Effective date: 20150407 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150407 Address after: 050000 Hebei province Shijiazhuang City Qiaodong District Huai Road No. 1 Applicant after: Wu Qinghe Applicant after: Han Jiulong Address before: 050000 Hebei province Shijiazhuang City Qiaodong District Huai Road No. 1 Applicant before: SHIJIAZHUANG MENGYU BIOLOGICAL SCIENCE & TECHNOLOGY CO., LTD. |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141001 |
|
| RJ01 | Rejection of invention patent application after publication |